文献速递肾移植

社会经济剥夺与肾移植结局

Socioeconomic Deprivation and Kidney Transplant Outcomes.
PubMed 文献 · Kidney Int Rep · 2025-11-05

该研究纳入比利时鲁汶大学医院1891例肾移植受者(2004-2021年),用比利时多重剥夺指数评估社会经济剥夺。单变量分析中剥夺与全因移植物衰竭相关(HR 1.07),校正后无关联;排斥风险在各剥夺组间有差异(P=0.030),主要由T细胞介导排斥较高驱动(aHR 1.08)。

要点

  • 校正后社会经济剥夺与全因移植物衰竭、移植物衰竭、死亡率均无显著关联。
  • 排斥风险在各剥夺组间差异显著,T细胞介导排斥风险随剥夺增加(aHR 1.08)。
  • 抗体介导排斥与剥夺无关联,提示全民医疗可能减轻部分不良结局。

核心结论

  • 比利时社会经济剥夺与排斥(特别是T细胞介导排斥)相关,单变量分析与全因移植物衰竭相关。
  • 未发现剥夺与移植物衰竭或死亡率分别存在关联的证据。
  • 全民医疗可能减轻社会经济剥夺导致的部分移植后不良结局。

研究设计与样本

  • 回顾性研究,纳入比利时鲁汶大学医院2004-2021年1891例肾移植受者。
  • 使用比利时多重剥夺指数(BIMD)评估社会经济剥夺。
  • 采用Cox模型和竞争风险模型分析全因移植物衰竭、移植物衰竭、死亡率和排斥。

主要发现

  • 单变量分析中剥夺与全因移植物衰竭相关(HR 1.07,95%CI 1.00-1.14,P=0.043),校正后无关联(aHR 1.03,95%CI 0.97-1.10,P=0.315)。
  • 移植物衰竭校正后无显著关联(aHR 1.04,95%CI 0.94-1.15,P=0.467)。
  • 死亡率校正后无显著关联(aHR 1.04,95%CI 0.96-1.13,P=0.366)。
  • 排斥风险在各剥夺组间差异显著(P=0.030),T细胞介导排斥风险较高(aHR 1.08,95%CI 1.00-1.16,P=0.036)。
  • 抗体介导排斥无关联(aHR 1.00,95%CI 0.88-1.15,P=0.984)。

临床怎么用

  • 肾移植受者评估中可关注社会经济剥夺,尤其针对T细胞介导排斥风险较高者。
  • 全民医疗背景下,剥夺对移植物衰竭和死亡率的独立影响可能有限。
  • 未来需评估剥夺是否影响移植可及性。

局限性

  • 单中心回顾性研究,样本来自比利时鲁汶大学医院。
  • 未评估剥夺对移植可及性的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Socioeconomic deprivation adversely affects health outcomes, including those after kidney transplantation. Retrospective studies, including 92,844 patients in the US and 19,103 and 621 in 2 UK cohorts, reported higher mortality and graft rejection among deprived individuals. The persistence of these disparities in the UK, despite having universal health care, suggests that insurance coverage alone does not eliminate inequities. Whether similar patterns exist in Belgium remains unclear. METHODS: We studied 1891 kidney transplant recipients (2004-2021) at University Hospitals Leuven, by assessing socioeconomic deprivation using the Belgian Index of Multiple Deprivation (BIMD). The outcomes were all-cause graft failure, graft failure, mortality, and rejection, analyzed with Cox and competing risks models. RESULTS: Socioeconomic deprivation was associated with all-cause graft failure in univariable analysis (hazard ratio [HR]: 1.07, 95% confidence interval [CI]: 1.00-1.14, P = 0.043), but not after adjustment (adjusted HR [aHR]: 1.03, 95% CI: 0.97-1.10, P = 0.315). No significant associations were observed for graft failure (aHR: 1.04, 95% CI: 0.94-1.15, P = 0.467) or mortality (aHR: 1.04, 95% CI: 0.96-1.13, P = 0.366). In contrast, rejection risk differed significantly across deprivation groups (P = 0.030), driven by higher rates of T-cell-mediated rejection (TCMR) (aHR: 1.08, 95% CI: 1.00-1.16, P = 0.036), whereas antibody-mediated rejection (AMR) showed no association (aHR: 1.00, 95% CI: 0.88-1.15, P = 0.984). CONCLUSION: Socioeconomic deprivation in Belgium was associated with rejection, specifically TCMR, and univariably with all-cause graft failure. We lacked evidence of associations with graft failure or mortality separately. These findings suggest that universal health care may mitigate some adverse posttransplantation outcomes because of socioeconomic deprivation. Future studies should evaluate whether deprivation affects access to transplantation itself.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ponette L, Wellekens K, Koshy P, et al. Socioeconomic Deprivation and Kidney Transplant Outcomes. Kidney Int Rep. 2025. PMID: 41502807. doi:10.1016/j.ekir.2025.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。